Aelix conducts phase I trial of DNA.HTI and MVA.HTI in HIV-1-positive patients July 27, 2017 No Comments
MK-8591 shows promise as a novel HIV prophylaxis drug in preclinical and early clinical setting July 27, 2017 No Comments
Phase III data for glecaprevir/pibrentasvir combination in HIV-1/HCV coinfected patients presented July 26, 2017 No Comments
Gilead Sciences' MAA for bictegravir/emtricitabine/tenofovir alafenamide FDC validated by EMA July 14, 2017 No Comments
RSS